Rabbit Recombinant Monoclonal 5-Methylcytosine antibody. Suitable for ICC, Flow Cyt, ELISA, Dot, MeDIP, IHC-P and reacts with Modified Nucleic Acid samples. Cited in 18 publications. Immunogen corresponding to Chemical / Small Molecule corresponding to 5-Methylcytosine.
IgG
Rabbit
Preservative: 0.09% Sodium azide
Constituents: 50% Glycerol (glycerin, glycerine), 48% PBS, 1% BSA
Liquid
Monoclonal
ICC | Flow Cyt | ELISA | Dot | MeDIP | IHC-P | |
---|---|---|---|---|---|---|
Modified Nucleic Acid | Tested | Tested | Tested | Tested | Tested | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Modified Nucleic Acid | Dilution info 0.5-2 µg/mL | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Modified Nucleic Acid | Dilution info 0.5-2 µg/mL | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Modified Nucleic Acid | Dilution info 0.1-3 µg/mL | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Modified Nucleic Acid | Dilution info 1/0.5 - 1/2 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Modified Nucleic Acid | Dilution info 0.2-2 µg/mL | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Modified Nucleic Acid | Dilution info - | Notes - |
Select an associated product type
5 Methycytosine, 5-Me Cytidine, 5-Me Cytosine, 5-Methyl-Cytidine, 5-Methyl-Cytosine, 5-MethylCytidine, 5-MethylCytosine, 5-mC, 5-meC, methyl CpG
Rabbit Recombinant Monoclonal 5-Methylcytosine antibody. Suitable for ICC, Flow Cyt, ELISA, Dot, MeDIP, IHC-P and reacts with Modified Nucleic Acid samples. Cited in 18 publications. Immunogen corresponding to Chemical / Small Molecule corresponding to 5-Methylcytosine.
5 Methycytosine, 5-Me Cytidine, 5-Me Cytosine, 5-Methyl-Cytidine, 5-Methyl-Cytosine, 5-MethylCytidine, 5-MethylCytosine, 5-mC, 5-meC, methyl CpG
IgG
Rabbit
Preservative: 0.09% Sodium azide
Constituents: 50% Glycerol (glycerin, glycerine), 48% PBS, 1% BSA
Liquid
Monoclonal
RM231
Affinity purification Protein A
ab214727 reacts to 5-methylcytosine in both single-stranded and double-stranded DNA. No cross reactivity with non-methylated cytosine and hydroxymethylcytosine in DNA.
Blue Ice
1-2 weeks
+4°C
-20°C
Upon delivery aliquot
Avoid freeze / thaw cycle
This supplementary information is collated from multiple sources and compiled automatically.
5-methylcytosine often referred to as 5-mC 5-methyl cytosine or 5-methylcytidine is a methylated form of the nucleobase cytosine found in the DNA of various organisms. This modification typically occurs at the carbon 5 position of the cytosine ring contributing to the epigenetic regulation of gene expression. While the mass of 5-mC itself is relatively small since it is a modified nucleotide its impact on gene regulation is significant. 5-mC is widely expressed in the genome of higher eukaryotes particularly in CpG dinucleotides where it plays a role in mammalian development and cell differentiation.
Cytosine methylation affects DNA-protein interactions leading to changes in chromatin structure and the regulation of gene activity. 5-methylcytosine is an important player in the chromatin modification complex where it collaborates with other epigenetic marks to control gene expression profiles. This modified nucleotide helps to stabilize gene silencing maintaining the closed chromatin state which inhibits the transcription machinery's access to specific genomic regions. Such silencing is vital during processes like X-chromosome inactivation and imprinting.
Researchers have identified 5-mC within two critical pathways: DNA methylation and demethylation cycle and histone modification pathway. In the DNA methylation pathway 5-mC interacts closely with proteins like DNA methyltransferases (DNMTs) which directly add methyl groups to cytosine bases. In the context of histone modification 5-mC influences the binding of methyl-CpG-binding domain (MBD) proteins which read and interpret methylated DNA marks affecting histone modification and DNA accessibility.
The dysregulation of 5-methylcytosine patterns associates prominently with cancer and neurological disorders. Abnormal methylation patterns where 5-mC is either hypermethylated or hypomethylated can lead to the silencing of tumor suppressor genes or activation of oncogenes forming a basis for cancer development. In neurological disorders altered 5-mC levels link to conditions such as Rett syndrome where the dysfunction of the associated protein MeCP2 an important reader of 5-mC contributes to the disease pathology.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Immunocytochemical analysis of HeLa cells using two different fixation/denaturation conditions and ab214727 at 2 μg/mL dilution (red); actin filaments have been labeled with fluorescein phalloidin (green), and nuclei stained with DAPI (blue).
Chromatin denaturation is required to expose the epitopes in DNA and allow the antibody to efficiently detect 5mC. Stronger denaturing conditions such as HCl (bottom panels) will result in enhanced nuclear staining compared to weaker denaturing conditions such as acetic acid (HAc, top panels).
However, stronger denaturants such as using HCl may alter or degrade other molecules and intracellular structures, which can be problematic for experiments involving multi-color staining or looking at subcellular morphology. For those experiments we would suggest using weaker denaturants such as HAc.
Direct ELISA of HeLa cell genomic DNA using anti-5-mC antibody (RM231). The plate was directly coated with different concentrations of genomic DNA isolated from HeLa cells. 1 ug/mL or 3 ug/mL of ab214727 was used as the primary antibody, and a HRP conjugated anti-rabbit IgG as the secondary antibody.
MeDIP was performed using anti-5-mC antibody (RM231) at a 2:1 DNA:Ab ratio. 1 ng of unmethylated, 5-Methylcytosine (5-mC) or 5-Hydroxymethylcytosine (5-hmC) DNA standard (897 bp) was spiked in 1ug of genomic DNA isolated from HeLa cells as the control. Realtime PCR was then performed to determine the capture of DNA standard as in % of input.
Flow Cytometry analysis of 5-mC expression in HEK293 cells using ab214727. The cells were fixed with ice-cold MeOH, permeabilized with 0.5% Triton X-100, denatured with 2N HCl, then stained with ab214727 (Blue) or with a negative control antibody (Red).
Dot blot of double stranded DNA using ab214727 at 0.5 ug/mL. The membrane was pre-spotted with 50, 5, and 0.5 ng/dot of double stranded
5-Hydroxymethylcytosine (5-hmC) DNA, 5-Methylcytosine
(5-mC) DNA, and unmethylated DNA. The pre-spotted
membrane was then blotted with ab214727.
ELISA of single stranded DNA using ab214727 in a serial dilution. The plate was coated with streptavidin and then biotinylated single stranded
unmethylated DNA, 5-Methylcytosine (5-mC) DNA, and
5-Hydroxymethylcytosine (5-hmC) DNA. Secondary antibody: alkaline phosphatase conjugated anti-rabbit IgG
.
ab214727 staining 5-methylcytosine (5-mC) in human brain tissue sections by Immunohistochemistry (paraformaldehyde-fixed, paraffin-embedded sections). Tissue was blocked with 5% normal goat serum for 60 minutes at 22°C. Samples were incubated with primary antibody (20ng/ml) for 1 hour at 22°C. A HRP-conjugated Goat anti-rabbit IgG polyclonal was used as the secondary antibody.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com